Open AccessTuberculosis Prevention in the Private Sector: Using Claims-Based Methods to Identify and Evaluate Latent Tuberculosis Infection Treatment With Isoniazid Among the Commercially Insured
Author(s) -
Erica L. Stockbridge,
Thaddeus L. Miller,
Erin Carlson,
Christine Ho
Publication year - 2018
Publication title -
journal of public health management and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.771
H-Index - 50
eISSN - 1550-5022
pISSN - 1078-4659
DOI - 10.1097/phh.0000000000000628
Subject(s) - isoniazid , tuberculosis , latent tuberculosis , medicine , tuberculosis prevention , environmental health , mycobacterium tuberculosis , pathology
Targeted identification and treatment of people with latent tuberculosis infection (LTBI) are key components of the US tuberculosis elimination strategy. Because of recent policy changes, some LTBI treatment may shift from public health departments to the private sector.